YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Netflix downgraded, SanDisk initiated: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled…
Quince Therapeutics, Inc. SOUTH SAN FRANCISCO, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Quince Therapeutics, Inc. (Nasdaq: QNCX), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapies…
(RTTNews) - Today's top gainers in the biotech space include NextCure, ahead of its planned merger with a private company that will create a newly branded public entity; Basel Medical, which recently regained Nasdaq compliance; and Outlook…
Data from Phase 2a study of LAM-001 on top of standard of care in PH-ILD patients with refractory PH demonstrated clinically meaningful improvement in multiple assessments of lung function, including improvement in 6MWD of 67.4 meters and…
Acquisition includes LAM-001, an inhaled formulation of rapamycin for multiple pulmonary diseases, including pulmonary hypertension associated with interstitial lung disease (PH-ILD) and bronchiolitis obliterans syndrome post lung transpla…
* Quince Therapeutics (QNCX [https://seekingalpha.com/symbol/QNCX]) settled its outstanding ~$16.4M EIB loan [https://seekingalpha.com/pr/20455197-quince-therapeutics-settles-approximately-16_4-million-of-debt] at a discounted payoff of $5…
NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Kala Bio Inc. 192,018,255 0.51 0.405 0.4079 +0.114 Actelis Networks Inc. 1…
NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Blue Hat Interac.Entert.Techn. 1,155,662,417 0.0627 0.0447 0.05 +0.0207 El…
NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Classover Holdings Inc. 225,318,969 0.1393 0.116 0.1208 +0.0251 XWELL Inc.…
NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Olb Group Inc. 156,982,412 0.977 0.66 0.8821 +0.467 Gaxos.ai Inc. 73,210,7…
NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Iveda Solutions Inc. 145,947,936 0.42 0.3698 0.3833 +0.0933 Quince Therape…
NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change SCWorx Corp. 128,837,220 0.325 0.2036 0.2716 +0.0861 Jet.AI Inc. 94,349,76…
NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change RenX Enterprises Corp. 554,830,890 0.35 0.2621 0.2829 +0.1429 Classover Ho…
NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Quince Therapeutics Inc. 431,482,875 0.337 0.2459 0.2623 +0.1323 Phio Phar…
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Citi upgraded Spotify (SPOT) to Buy from N…
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Citi upgraded Spotify (SPOT) to Buy from N…
D. Boral Capital analyst Jason Kolbert raised the firm’s price target on Quince Therapeutics (QNCX) to $5 from $4 and keeps a Buy rating on the shares after the company said the last patient has completed their last visit in the pivotal Ph…
* Aqua Metals (NASDAQ:AQMS [https://seekingalpha.com/symbol/AQMS]) has filed to sell 1M shares of common stock for holders. * This prospectus is not an offer to sell these securities. * Filing [https://seekingalpha.com/filing/10490250] MOR…
Marks major milestone with completion of enrollment in pivotal Phase 3 NEAT clinical trial evaluating lead asset, eDSP, for the treatment of A-T; topline results expected in first quarter of 2026 Closed financing priced at a premium bringi…
Provides access to broad-reaching nationwide network of specialty pharmacy and ambulatory infusion suites across the U.S. SOUTH SAN FRANCISCO, Calif. & BANNOCKBURN, Ill., August 07, 2025--(BUSINESS WIRE)--Quince Therapeutics, Inc. (Nasdaq:…
* Quince Therapeutics (NASDAQ:QNCX [https://seekingalpha.com/symbol/QNCX]) has registered up to 17.34M shares of common stock for resale by selling stockholders. * The registration includes 6.67M existing shares and up to 10.67M shares iss…
* Quince Therapeutics (NASDAQ:QNCX [https://seekingalpha.com/symbol/QNCX]) announces a private placement expected to generate $11.5M in upfront proceeds. * The deal includes common stock (or pre-funded warrants) and accompanying common war…
Wall Street wrapped up the week with a bang, as a solid jobs report and a possible thaw in US-China trade tensions gave investors plenty to cheer about. Protect Your Portfolio Against Market Uncertainty Discover companies with rock-solid f…
SOUTH SAN FRANCISCO, Calif., August 04, 2022--(BUSINESS WIRE)--Quince Therapeutics, Inc. (Nasdaq: QNCX), a biopharmaceutical company advancing innovative precision therapeutics targeting debilitating and rare diseases, today announced that…
Strategic focus centered on advancing innovative precision therapeutics for debilitating and rare diseases Highly differentiated bone-targeting drug platform and lead precision bone growth molecule NOV004 to address underserved therapeutic…
New ticker symbol (Nasdaq: QNCX) to initiate trading on August 1, 2022 SOUTH SAN FRANCISCO, Calif., July 27, 2022--(BUSINESS WIRE)--Cortexyme, Inc. (Nasdaq: CRTX) today announced that the company’s planned corporate name change to Quince T…